This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Harbin Hongdoushan Bio-Pharm Co., Ltd., Heilongjiang Hongdoushan Pharmaceutical Co., Ltd., Shanghai Kairun Biology Medicine Limited Liability Company. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2017
Title: Zhiguo Wang: Innovator in Thromboembolic Disease Treatment
Introduction
Zhiguo Wang is a notable inventor based in Shangzhi, China. He has made significant contributions to the field of medicine, particularly in the development of treatments for thromboembolic diseases. His innovative approach has led to the creation of a unique drug formulation that utilizes depolymerized holothurian glycosaminoglycans (DHG).
Latest Patents
Zhiguo Wang holds a patent for the "Application of depolymerized holothurian glycosaminoglycans (DHG) in preparation of drug for prevention and treatment of thromboembolic diseases." This invention reveals the application of DHG, which consists of multiple types with weight-average molecular weights between 26,000 and 45,000 Da. The drug demonstrates a significant anticoagulant effect when administered intravenously or subcutaneously, while also exhibiting minimal side effects. The formulation is effective in preventing and treating thromboembolic diseases, enhancing blood coagulation time as the dosage increases.
Career Highlights
Zhiguo Wang has worked with several prominent companies in the biotechnology sector. He has been associated with Shanghai Kairun Biology Medicine Limited Liability Company and Harbin Hongdoushan Bio-pharm Co., Ltd. His work in these organizations has contributed to advancements in medical treatments and drug development.
Collaborations
Throughout his career, Zhiguo Wang has collaborated with notable colleagues, including Quanhai Liu and Xuehai Wu. These partnerships have fostered innovation and have been instrumental in the progress of his research and development efforts.
Conclusion
Zhiguo Wang's contributions to the field of medicine, particularly in the treatment of thromboembolic diseases, highlight his role as an influential inventor. His patented work with DHG showcases the potential for innovative drug formulations to improve patient outcomes.